ALKBH7 and cancer: Based on Cell Miner and GDSC data, the analysis of IC50 values of different drugs in pan-cancer reveals that high ALKBH7 expression might be sensitive to most anti-cancer drugs, such as Palbociclib, Dovitinib, Vandetanib, Trametinib, Mirdametinib, and Pluripotin.